Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Nantahala Capital Management, LLC TELA TELA Bio, Inc. 13G/A 12.94% 3mo
AQR CAPITAL MANAGEMENT LLC BXBL BOXABL Inc. 13G/A 0% 3mo
Point72 Asset Management, L.P. STRO Sutro Biopharma, Inc. 13G/A 1.4% 3mo
Point72 Asset Management, L.P. JANX Janux Therapeutics, Inc. 13G/A 3.3% 3mo
Paradigm Biocapital Advisors LP EWTX Edgewise Therapeutics, Inc. 13G/A 9.5% 3mo
LMR Partners LLP NHIV NewHold Investment Corp IV 13G 7% 3mo
CITADEL ADVISORS LLC DGXX Digi Power X Inc. 13G/A 2.3% 3mo
ALLIANCEBERNSTEIN L.P. CBK Commercial Bancgroup, Inc. 13G/A 6.2% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ GH Guardant Health, Inc. 13G/A 4.9% 3mo
PERCEPTIVE ADVISORS LLC SYRE Spyre Therapeutics, Inc. 13G/A 4.9% 3mo
Broad Bay Capital Management, LP BATRA Atlanta Braves Holdings, Inc. 13G/A 3.87% 3mo
EdgePoint Investment Group Inc. TWST Twist Bioscience Corp 13G/A 4.21% 3mo
ARMISTICE CAPITAL, LLC DCOY Decoy Therapeutics Inc. 13G 9.99% 3mo
ORBIMED ADVISORS LLC LXEO Lexeo Therapeutics, Inc. 13G 4.1% 3mo
Nantahala Capital Management, LLC HLSQ Tessera Defense & Homeland Security Inc. 13G/A 7.13% 3mo
First Trust Capital Management L.P. SIMA SIM Acquisition Corp. I 13G/A 0% 3mo
METEORA CAPITAL, LLC GTEN Gores Holdings X, Inc. 13G/A 5.9% 3mo
Anson Funds Management LP SSM Sono Group N.V. 13G/A 9.9% 3mo
ANDERA PARTNERS EVMN Evommune, Inc. 13G/A 3.9% 3mo
Ikarian Capital, LLC TENX Tenax Therapeutics, Inc. 13G/A 2.9% 3mo
WHITEBOX ADVISORS LLC UP Wheels Up Experience Inc. 13G/A 2.8% 3mo
T. Rowe Price Investment Management, Inc. PRAA Pra Group Inc 13G/A 7.9% 3mo
Orbis Investment Management Limited FSV FirstService Corp 13G/A 7.3% 3mo
RA CAPITAL MANAGEMENT, L.P. CCCC C4 Therapeutics, Inc. 13G/A 9.9% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ FTI TechnipFMC plc 13G/A 6.5% 3mo
Lagoda Investment Management, L.P. DMRC Digimarc Corp 13G 5% 3mo
Ikarian Capital, LLC KZIA Kazia Therapeutics Ltd 13G/A 4.9% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ XPRO Expro Ltd 13G/A 12.5% 3mo
Harraden Circle Investments, LLC ALDFF Aldel Financial II Inc. 13G/A 9.92% 3mo
ADAR1 Capital Management, LLC OVID Ovid Therapeutics Inc. 13G/A 5.1% 3mo
METEORA CAPITAL, LLC XCBE X3 Acquisition Corp. Ltd. 13G/A 6.26% 3mo
Matthew Hulsizer REI Ring Energy, Inc. 13G 6.6% 3mo
SOUTHEASTERN ASSET MANAGEMENT INC/TN/ SHEN Shenandoah Telecommunications Co 13G/A 4.7% 3mo
ARISTEIA CAPITAL, L.L.C. PTOR Praetorian Acquisition Corp. 13G 5.3% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC BREZ Breeze Acquisition Corp. II 13G 5.9% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ AMBA Ambarella Inc 13G 5.9% 3mo
Orbis Investment Management Limited MICC Magnum Ice Cream Co N.V. 13G/A 4.7% 3mo
Ionic Ventures, LLC BTCY Biotricity Inc. 13G/A 9.9% 3mo
CITADEL ADVISORS LLC CRBP Corbus Pharmaceuticals Holdings, Inc. 13G/A 1.1% 3mo
Valiant Capital Management, L.P. CORZ Core Scientific, Inc. 13G/A 5.3% 3mo
1607 Capital Partners, LLC NUW Nuveen AMT-Free Municipal Value Fund 13G/A 4.48% 3mo
First Trust Capital Management L.P. GPAT GP-Act III Acquisition Corp. 13G/A 0% 3mo
Alyeska Investment Group, L.P. VOYG Voyager Technologies, Inc. 13G/A 1.16% 3mo
Point72 Asset Management, L.P. AIB AIB Data Centers Inc. 13G/A 6.6% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC OCAC Ocean Capital Acquisition Corp 13G 6.1% 3mo
Lynwood Capital Management Inc. RNTX Rein Therapeutics, Inc. 13G/A 5% 3mo
PureTech Health plc SPTX Seaport Therapeutics, Inc. 13G 31.2% 3mo
Harraden Circle Investments, LLC CEPS Cantor Equity Partners VI, Inc. 13G/A 6.47% 3mo
Carlyle Group Inc. SPWR SunPower Inc. 13G/A 4.4% 3mo
TCG Crossover GP II, LLC ALXO Alx Oncology Holdings Inc 13G/A 4.2% 3mo